Valuation: Implanet SA

Market Cap 20.91M 23.3M 19.31M 17.51M 32.73M 2.21B 33.13M 231M 91.94M 1.16B 87.46M 85.59M 3.68B P/E 2024
-2.85x
P/E 2025 -5.8x
Enterprise Value 23.83M 26.55M 22M 19.95M 37.29M 2.52B 37.75M 264M 105M 1.32B 99.65M 97.52M 4.19B EV / Sales 2024
2x
EV / Sales 2025 2.23x
Free-Float
33.85%
Yield 2024 *
-
Yield 2025 -
1 day-5.58%
1 week-4.97%
Current month-9.12%
1 month-11.02%
3 months-13.45%
6 months-27.30%
Current year-26.75%
1 week 0.13
Extreme 0.1312
0.15
1 month 0.13
Extreme 0.1312
0.19
Current year 0.13
Extreme 0.1312
0.29
1 year 0.13
Extreme 0.1312
0.29
3 years 0.04
Extreme 0.035
0.45
5 years 0.04
Extreme 0.035
0.58
10 years 0.04
Extreme 0.035
38
Manager TitleAgeSince
Chief Executive Officer - 27/11/2012
Director of Finance/CFO - 01/09/2015
Chief Operating Officer - -
Director TitleAgeSince
Chairman 71 06/04/2011
Director/Board Member - 22/01/2013
Director/Board Member - 10/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
-5.58%-4.97%-45.54%+176.95% 24.77M
-1.70%+0.63%-18.93%+11.04% 181B
-1.54%-0.98%-21.45%+15.09% 117B
-0.89%-0.72%-0.19%+35.32% 116B
+3.89%+20.80%-42.56%+8.20% 89.94B
-1.40%-5.21%-3.18%+73.40% 62.97B
-0.25%-0.70%+10.47%+83.73% 55.43B
-0.69%+0.63%+4.27%-22.48% 53.49B
-1.57%+0.60%-13.31%+43.41% 44.92B
-0.66%+3.26%-4.83%-8.81% 33.87B
Average -1.03%+1.58%-13.52%+41.58% 75.56B
Weighted average by Cap. -0.62%+2.30%-13.18%+24.26%

Financials

2024 2025
Net sales 9.41M 10.48M 8.69M 7.88M 14.72M 995M 14.9M 104M 41.35M 522M 39.34M 38.5M 1.65B 12.47M 13.9M 11.52M 10.44M 19.52M 1.32B 19.76M 138M 54.84M 692M 52.17M 51.06M 2.19B
Net income -4.37M -4.86M -4.03M -3.66M -6.83M -462M -6.92M -48.33M -19.2M -242M -18.26M -17.87M -768M -4.38M -4.88M -4.05M -3.67M -6.86M -464M -6.94M -48.51M -19.27M -243M -18.33M -17.94M -771M
Net Debt 4.57M 5.09M 4.22M 3.83M 7.15M 484M 7.24M 50.58M 20.09M 253M 19.11M 18.7M 804M 2.92M 3.25M 2.69M 2.44M 4.56M 309M 4.62M 32.27M 12.82M 162M 12.19M 11.93M 513M
Projected Income Statement - Annual - Implanet SA
Logo Implanet SA
Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).
Employees
49
Date Price Change Volume
27/10/26 €0.1454 -5.58% 19,956
26/10/26 €0.1540 +1.32% 26,725
23/10/26 €0.1520 +2.01% 139,200
22/10/26 €0.1490 -2.87% 38,203
21/10/26 €0.1534 +0.26% 7,894
  1. Stock Market
  2. Stocks
  3. ALIMP Stock